Ambalal Sarabhai

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE432A01017
NSEID:
BSEID: 500009
View on BSE

INR

27.02

2.21 (8.91%)

BSENSE

Mar 13

BSE+NSE Vol: 2.98 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Quest Laborato.

Auro Labs.

Syschem (India)

Ambalal Sarabhai

Brooks Lab.

Coral Labs.

Transchem

Oxygenta Pharma

Aarey Drugs

Lyka Labs

Astonea Labs

Why is Ambalal Sarabhai Enterprises Ltd ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.55%

Poor long term growth as Net Sales has grown by an annual rate of 5.57% over the last 5 years

Underperformed the market in the last 1 year

Even though the market (BSE500) has generated returns of 5.44% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -26.07% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ambalal Sarabhai for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Ambalal Sarabhai

-26.07%

-0.60

43.46%

Sensex

1.0%

0.08

12.13%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

5.57%

EBIT Growth (5y)

24.54%

EBIT to Interest (avg)

2.80

Debt to EBITDA (avg)

3.40

Net Debt to Equity (avg)

0.23

Sales to Capital Employed (avg)

1.14

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.35%

ROCE (avg)

4.36%

ROE (avg)

19.42%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.40

EV to EBIT

31.85

EV to EBITDA

20.96

EV to Capital Employed

1.33

EV to Sales

1.19

PEG Ratio

0.35

Dividend Yield

ROCE (Latest)

1.51%

ROE (Latest)

11.27%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

PBT LESS OI(Q)

At Rs 2.60 cr has Grown at 817.2% (vs previous 4Q average

ROCE(HY)

Highest at 10.22%

PAT(9M)

Higher at Rs 11.98 Cr

-3What is not working for the Company

PAT(Latest six months)

At Rs 3.76 cr has Grown at -22.38%

NON-OPERATING INCOME(Q)

is 49.81 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Ambalal Sarabhai

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 2.60 cr has Grown at 817.2% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs -0.36 Cr

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Here's what is not working for Ambalal Sarabhai

Profit After Tax (PAT) - Latest six months

At Rs 3.76 cr has Grown at -22.38%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is negative

PAT (Rs Cr)

Non Operating Income - Quarterly

is 49.81 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT